Cellyan Biotechnology Co Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| STONEX GROUP INC. | 08/12/2026 | 102.31 K | $52.36 K | 159.70% | 0.28% |
| JANE STREET GROUP, LLC | 08/14/2026 | 49.09 K | $18.65 K | 100.00% | 0.14% |
| HRT FINANCIAL LP | 08/14/2026 | 41.82 K | $15.00 K | 100.00% | 0.12% |
| XTX TOPCO LTD | 08/14/2026 | 38.93 K | $14.79 K | 100.00% | 0.11% |
| CLEAR STREET GROUP INC. | 08/12/2026 | 12.02 K | $4.57 K | 0.00% | 0.03% |
| UBS GROUP AG | 08/13/2026 | 1.08 K | $411 | 882.73% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cellyan Biotechnology Co Ltd. institutional Ownership - FAQ's
During the previous two years, 8 institutional investors and hedge funds held shares of Cellyan Biotechnology Co Ltd.. The most heavily invested institutionals were:
StoneX Group Inc.: 102,310
JANE STREET GROUP, LLC: 49,087
HRT FINANCIAL LP: 41,824
XTX Topco Ltd: 38,930
Clear Street Group Inc.: 12,019
UBS Group AG: 1,081
0.68% of Cellyan Biotechnology Co Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 257.27 K shares in the last 24 months. This purchase volume represents approximately $162.08 K in transactions.